BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2536 related articles for article (PubMed ID: 17921903)

  • 1. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
    Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
    Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.
    Arts HA; Telian SA; El-Kashlan H; Thompson BG
    Otol Neurotol; 2006 Feb; 27(2):234-41. PubMed ID: 16436995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nerve branch of origin and extracanalicular extension of the tumor on hearing after middle fossa removal of vestibular schwannoma.
    Fiscina F; Gouveris H; Mann W
    Acta Otolaryngol; 2007 Oct; 127(10):1058-61. PubMed ID: 17851965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial nerve outcomes in middle cranial fossa vs translabyrinthine approaches.
    Isaacson B; Telian SA; El-Kashlan HK
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):906-10. PubMed ID: 16360512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of facial nerve function results after translabyrinthine and retrosigmoid approach in medium-sized tumors.
    Mamikoglu B; Esquivel CR; Wiet RJ
    Arch Otolaryngol Head Neck Surg; 2003 Apr; 129(4):429-31. PubMed ID: 12707190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of jugular foramen schwannomas with hearing and facial nerve function preservation: a series of 23 cases and review of the literature.
    Sanna M; Bacciu A; Falcioni M; Taibah A
    Laryngoscope; 2006 Dec; 116(12):2191-204. PubMed ID: 17146395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing preservation in conservation surgery for vestibular schwannoma.
    Holsinger FC; Coker NJ; Jenkins HA
    Am J Otol; 2000 Sep; 21(5):695-700. PubMed ID: 10993461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing preservation in neurofibromatosis type 2.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vestibular schwannoma volume as a predictor of hearing outcome after surgery.
    Gjuric M; Mitrecic MZ; Greess H; Berg M
    Otol Neurotol; 2007 Sep; 28(6):822-7. PubMed ID: 17554228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional outcome of retrosigmoid approach in vestibular schwannoma surgery.
    Yang J; Grayeli AB; Barylyak R; Elgarem H
    Acta Otolaryngol; 2008 Aug; 128(8):881-6. PubMed ID: 18607969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic vestibular schwannoma: classification, management, and facial nerve outcomes.
    Piccirillo E; Wiet MR; Flanagan S; Dispenza F; Giannuzzi A; Mancini F; Sanna M
    Otol Neurotol; 2009 Sep; 30(6):826-34. PubMed ID: 19704364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing preservation using the middle fossa approach for the treatment of vestibular schwannoma.
    Kutz JW; Scoresby T; Isaacson B; Mickey BE; Madden CJ; Barnett SL; Coimbra C; Hynan LS; Roland PS
    Neurosurgery; 2012 Feb; 70(2):334-40; discussion 340-1. PubMed ID: 21826031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hearing preservation after middle fossa removal of vestibular schwannoma.
    Friedman RA; Kesser B; Brackmann DE; Fisher LM; Slattery WH; Hitselberger WE
    Otolaryngol Head Neck Surg; 2003 Dec; 129(6):660-5. PubMed ID: 14663432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial nerve function and hearing preservation acoustic tumor surgery: does the approach matter?
    Hillman T; Chen DA; Arriaga MA; Quigley M
    Otolaryngol Head Neck Surg; 2010 Jan; 142(1):115-9. PubMed ID: 20096234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.
    Samii M; Matthies C; Tatagiba M
    Neurosurgery; 1997 Apr; 40(4):696-705; discussion 705-6. PubMed ID: 9092842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The learning curve in vestibular schwannoma surgery.
    Welling DB; Slater PW; Thomas RD; McGregor JM; Goodman JE
    Am J Otol; 1999 Sep; 20(5):644-8. PubMed ID: 10503588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vestibular schwannoma surgery outcomes: our multidisciplinary experience in 400 cases over 17 years.
    Darrouzet V; Martel J; Enée V; Bébéar JP; Guérin J
    Laryngoscope; 2004 Apr; 114(4):681-8. PubMed ID: 15064624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients.
    Samii M; Gerganov V; Samii A
    J Neurosurg; 2006 Oct; 105(4):527-35. PubMed ID: 17044553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 127.